UnknownNot Applicable

Endocrine Disrupting Chemicals and Hormones in ADHD

Taiwan240 participantsStarted 2019-07-12

Plain-language summary

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Growth hormone and thyroid function are associated with both physical and neurocognitive development. Endocrine disrupting chemicals (EDCs) could disturb the normal function of endocrine systems, and further link to the pathophysiology of ADHD. In addition, whether methylphenidate for treating ADHD influences growth hormone and thyroid function of patients remains unclear.

Who can participate

Age range6 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with ADHD aged between 6 and 16. * The patients were either newly diagnosed with ADHD or had an existing diagnosis but had not taken medication for ADHD during the previous 6 months or more. Exclusion Criteria: * Patients with a history of major physical or additional psychiatric diseases

What they're measuring

Growth hormone and thyroid function

Timeframe: Baseline

Growth hormone and thyroid function

Timeframe: month 12

Trial details

NCT IDNCT04970303

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Attention Deficit Hyperactivity Disorder trials